601 related articles for article (PubMed ID: 23647723)
1. Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review.
Schloss JM; Colosimo M; Airey C; Masci PP; Linnane AW; Vitetta L
Clin Nutr; 2013 Dec; 32(6):888-93. PubMed ID: 23647723
[TBL] [Abstract][Full Text] [Related]
2. Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.
Schloss J; Colosimo M; Vitetta L
Crit Rev Food Sci Nutr; 2017 Apr; 57(6):1107-1118. PubMed ID: 25849070
[TBL] [Abstract][Full Text] [Related]
3. A Narrative Review of Complementary Nutritional Supplements for Chemotherapy-induced Peripheral Neuropathy.
Liu YW; Liu CT; Su YL; Tsai MY
Altern Ther Health Med; 2020 Jul; 26(4):43-49. PubMed ID: 31634876
[TBL] [Abstract][Full Text] [Related]
4. The role of diet and non-pharmacologic supplements in the treatment of chronic neuropathic pain: A systematic review.
Frediani JK; Lal AA; Kim E; Leslie SL; Boorman DW; Singh V
Pain Pract; 2024 Jan; 24(1):186-210. PubMed ID: 37654090
[TBL] [Abstract][Full Text] [Related]
5. Natural products - alpha-lipoic acid and acetyl-L-carnitine - in the treatment of chemotherapy-induced peripheral neuropathy.
Dinicola S; Fuso A; Cucina A; Santiago-Reyes M; Verna R; Unfer V; Monastra G; Bizzarri M
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4739-4754. PubMed ID: 30058711
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
Wolf S; Barton D; Kottschade L; Grothey A; Loprinzi C
Eur J Cancer; 2008 Jul; 44(11):1507-15. PubMed ID: 18571399
[TBL] [Abstract][Full Text] [Related]
7. Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review.
Brami C; Bao T; Deng G
Crit Rev Oncol Hematol; 2016 Feb; 98():325-34. PubMed ID: 26652982
[TBL] [Abstract][Full Text] [Related]
8. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy-induced peripheral neuropathy].
Noguchi E; Maeda Y
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1773-6. PubMed ID: 22083183
[TBL] [Abstract][Full Text] [Related]
10. Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy.
Visovsky C; Collins M; Abbott L; Aschenbrenner J; Hart C
Clin J Oncol Nurs; 2007 Dec; 11(6):901-13. PubMed ID: 18063548
[TBL] [Abstract][Full Text] [Related]
11. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
Amara S
Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review.
De Grandis D
CNS Drugs; 2007; 21 Suppl 1():39-43; discussion 45-6. PubMed ID: 17696592
[TBL] [Abstract][Full Text] [Related]
13. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
Kuriyama A; Endo K
Support Care Cancer; 2018 Apr; 26(4):1051-1059. PubMed ID: 29280005
[TBL] [Abstract][Full Text] [Related]
14. Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy.
Bakogeorgos M; Georgoulias V
Expert Rev Anticancer Ther; 2017 Nov; 17(11):1045-1060. PubMed ID: 28868935
[TBL] [Abstract][Full Text] [Related]
15. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy.
Knoerl R; Weller E; Halpenny B; Berry D
BMC Cancer; 2018 Dec; 18(1):1203. PubMed ID: 30514351
[TBL] [Abstract][Full Text] [Related]
16. Integrative Approaches to Chemotherapy-Induced Peripheral Neuropathy.
Samuels N; Ben-Arye E
Curr Oncol Rep; 2020 Feb; 22(3):23. PubMed ID: 32048067
[TBL] [Abstract][Full Text] [Related]
17. The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP.
Streckmann F; Balke M; Lehmann HC; Rustler V; Koliamitra C; Elter T; Hallek M; Leitzmann M; Steinmetz T; Heinen P; Baumann FT; Bloch W
BMC Cancer; 2018 Jan; 18(1):62. PubMed ID: 29316888
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Recommendations.
Hou S; Huh B; Kim HK; Kim KH; Abdi S
Pain Physician; 2018 Nov; 21(6):571-592. PubMed ID: 30508986
[TBL] [Abstract][Full Text] [Related]
19. Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial.
Clavo B; Martínez-Sánchez G; Rodríguez-Esparragón F; Rodríguez-Abreu D; Galván S; Aguiar-Bujanda D; Díaz-Garrido JA; Cañas S; Torres-Mata LB; Fabelo H; Téllez T; Santana-Rodríguez N; Fernández-Pérez L; Marrero-Callico G
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802143
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced neuropathy: A comprehensive survey.
Miltenburg NC; Boogerd W
Cancer Treat Rev; 2014 Aug; 40(7):872-82. PubMed ID: 24830939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
